Fifth Lane Capital »

Fusion Pharmaceuticals shares owned by Fifth Lane Capital

Quarter-by-quarter ownership of Fusion Pharmaceuticals (FUSN) shares owned by Fifth Lane Capital from 13F filings

Historical chart of Fifth Lane Capital investment in Fusion Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Fusion Pharmaceuticals held by Fifth Lane Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fusion Pharmaceuticals by Fifth Lane Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $874k 41k 21.32

More positions owned by Fifth Lane Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Callon Petroleum (CPE)
Capri Holdings SHS (CPRI)
Axonics Modulation Technolog (AXNX)
Enviva Call Option (EVA)
Vizio Hldg Corp Cl A Com (VZIO)
Ib Acquisition Corp Unit 03/26/2029
3M Company Put Option (MMM)
Walt Disney Company (DIS)
Investcorp Europe Acquisitio Class A Ord Shs (IVCB)
Star Bulk Carriers Corp. Shs Par (SBLK)
Altc Acquisition Corp Com Cl A Call Option (ALCC)
McGrath Rent (MGRC)
Brookfield Renewable Corp Cl A Sub Vtg (BEPC)
Atlantic Union B (AUB)

View all positions for Fifth Lane Capital

Top funds holding Fusion Pharmaceuticals

Federated Investors
Perceptive Advisors
Avidity Partners Management
Deerfield Management Company
Fil
Pentwater Capital Management
Johnson & Johnson
Millennium Management
Tpg Gp A
TIG Advisors
FMR
Marshall Wace
Verition Fund Management
Qube Research & Technologies
William Blair $ Company

View all funds holding Fusion Pharmaceuticals